Abarelix0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Abarelix — research data
Regulatory statusFDA-approved (Plenaxis)
NCAA D1Banned
Overview
About Abarelix
Mechanism of action
GnRH receptor antagonist; immediate testosterone suppression without initial surge
Safety profile
Serious allergic reactions (boxed warning), QT prolongation · Approved for prostate cancer; immediate-onset allergic reaction risk led to restricted distribution
Related pages